HSBC Holdings
INMB icon

HSBC Holdings’s INmune Bio INMB Stock Holding History

HSBC Holdings’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,113
Closed -$60.4K – 2917
2025
Q2 		$60.4K Buy
28,113
+8,728
+45% +$64K ﹤0.01% 2914
2025
Q1 		$145K Sell
19,385
-5,826
-23% -$46.3K ﹤0.01% 2712
2024
Q4 		$119K Buy
25,211
+6,421
+34% +$33.5K ﹤0.01% 2857
2024
Q3 		$100K Buy
+18,790
New +$134K ﹤0.01% 2800

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's INMB Position: Q3 2025 in Review

HSBC Holdings sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 28,113 shares — an estimated $60.4K sold.

HSBC Holdings first reported a position in INMB in Q3 2024 and held it in 4 quarters. The position peaked at $145K in Q1 2025. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • HSBC Holdings reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 28,113 INmune Bio shares in Q3 2025, an estimated $60.4K.
  • HSBC Holdings first reported a position in INmune Bio in Q3 2024 and held it in 4 quarters.
  • HSBC Holdings's INmune Bio position peaked at $145K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.